In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Kyowa Kirin Co., Ltd.

https://www.kyowakirin.com/

Latest From Kyowa Kirin Co., Ltd.

Deal Watch: Bristol Accesses Tech Platforms From SyntheX, Autolus

Pharma will partner with SyntheX on targeted protein degradation, with Autolus on cell therapy safety. Novo Nordisk gets rights to Ventus’s lead compound in NASH and chronic kidney disease.

Deal Watch Business Strategies

Deal Watch: GSK Gets Rights To Spero’s Phase III Antibiotic

GSK takes equity stake in Spero, and global rights to tebipenem except for certain Asian markets. Merck KGaA gets rights to Nerviano’s next-generation PARP inhibitor for cancer.

Deal Watch Business Strategies

Deal Watch: Roche, PhoreMost Enter Into Multi-Target Collaboration

Plus deals with Synaffix/Emergence, Helsinn/Juniper and Sanyou/Shanghai KangaBio, while Takeda/Finch and Dong-A/Beactica ended prior collaborations. 

Deals Business Strategies

Step Pharma Aims To Become CTP Synthase 1 Leader, Starting With Aggressive Lymphoma

Emerging Company Profile: The French firm, which is developing the lead CTP synthase 1 inhibitor in the pipeline, plans to address a range of cancers with its highly selective approach.

Emerging Company Profile Companies
See All

Company Information

  • Industry
  • Biotechnology
  • In Vitro Diagnostics
  • Research, Analytical Equipment & Supplies
  • Pharmaceuticals
    • Nutraceuticals
    • Radiopharmaceuticals, Contrast Agents
  • Biotechnology
    • Drug Discovery Tools
  • Other Names / Subsidiaries
    • Archimedes Pharma Ltd.
    • Centus Biotherapeutics Ltd.
    • Daiichi Fine Chemical Co., Ltd.
    • Fujifilm Kyowa Kirin Biologics Co., Ltd.
    • Kirin Pharma Company, Limited
    • Kyowa Kirin Asia Pacific Pte. Ltd.
    • Kyowa Kirin Australia Pty Ltd
    • Kyowa Kirin International PLC
    • Kyowa Pharma Chemical Co., Ltd.
    • ProStrakan Group plc
    • Kyowa Kirin
    • Kyowa Kirin Frontier Co., Ltd.
    • Kyowa Hakko Kirin (Singapore) Pte. Ltd.
    • Kyowa Hakko Kirin Co., Ltd.
UsernamePublicRestriction

Register